Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pivot Pharmaceuticals Inc (PVOT.CN)

Pivot Pharmaceuticals Inc (PVOT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 25,656
  • Shares Outstanding, K 171,039
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.55
Trade PVOT.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.10
  • Most Recent Earnings $-0.02 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.120 +25.00%
on 11/20/19
0.160 -6.25%
on 12/05/19
unch (unch)
since 11/05/19
3-Month
0.120 +25.00%
on 11/20/19
0.370 -59.46%
on 09/09/19
-0.165 (-52.38%)
since 09/05/19
52-Week
0.120 +25.00%
on 11/20/19
0.520 -71.15%
on 05/24/19
-0.210 (-58.33%)
since 12/05/18

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pivot Pharmaceuticals Inc is engaged in the development and commercialization of therapeutic pharmaceutical products, focused on the strategy of identifying new therapeutic treatments to address unmet medical needs in women's health. Its pipeline products include PVT-009, PVT-010, PVT-011, PVT-012 and...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.167
1st Resistance Point 0.158
Last Price 0.150
1st Support Level 0.143
2nd Support Level 0.137
3rd Support Level N/A

See More

52-Week High 0.520
Fibonacci 61.8% 0.367
Fibonacci 50% 0.320
Fibonacci 38.2% 0.273
Last Price 0.150
52-Week Low 0.120

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar